108Labs logo — Pioneer of cell culture mammalian milk, developing Colostrup...

108Labs

Pioneer of cell culture mammalian milk, developing Colostrupedics™ whole-human infant formula and other dairy products

Founded 2013 United States Davis, United States 2-10 employees Biopharma, Biotechnology +1

General Information

Company Name 108Labs
Founded Year 2013
Location United States Davis, United States
Employees 2-10
Industries Biopharma, Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with 108Labs. To contact 108Labs, visit 108labs.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 108Labs compare?

A PDF of 108Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 108Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 108Labs

108Labs is leading the way in cell-cultured mammalian milk production, with a focus on developing Colostrupedics™ whole-human infant formula and other dairy products. Established in 2013, the company created the first cell-cultured human milk in January 2020 and is now focused on scaling up production through the buildout of the first smart Cellufacturing plant. This cutting-edge facility incorporates software, AI, hardware, and biotechnology to produce cell-cultured mammalian milk products at an industrial level. Their flagship product, Colostrupedics whole-human infant formula, is expected to revolutionize the infant nutrition market. While specifics about recent investments and investors are not currently available, 108Labs' positioning within the Biopharma, Biotechnology, and Pharmaceutical industries, combined with their headquarters in the United States, underscores their potential for significant impact within the food tech sector.

Business keywords: cell cultured milk, mammalian milk, Colostrupedics, whole-human infant formula, dairy products, smart Cellufacturing plant, cell culture, biotech startup, food technology, innovation, manufacturing technology

No funding data available for 108Labs yet.

108Labs Alternatives & Competitors

View All Alternatives
108Labs vs
ERGO
ERGO United States

We are a biotech startup focused on the development of complex animal proteins by plant cell precisi...

Seed
24 employees
Biopharma, Biotechnology
108Labs vs
Fermify
Fermify Austria

AI-driven precision fermentation platform producing sustainable food proteins

Corporate Round
28 employees
AI, Biopharma
108Labs vs

Leaders in biorreactor mixing

Grant
10 employees
Biotechnology, Pharmaceutical

FAQ About 108Labs

Pioneer of cell culture mammalian milk, developing Colostrupedics™ whole-human infant formula and other dairy products
108Labs was founded in 2013.
108Labs is headquartered in Davis, United States.
108Labs operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on cell cultured milk, mammalian milk, Colostrupedics and whole-human infant formula.
108Labs has approximately 2-10 employees.
Top alternatives and competitors to 108Labs include ERGO, Fermify, BioMixing S.L., Core Biogenesis, Symbiomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
108Labs and ERGO are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 108Labs, https://bouncewatch.com/company/108labs, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes